NDLI: Assessment of Whole-Genome Regression for Type II Diabetes

Content Provider	PubMed Central
Author	Vazquez, Ana I. Klimentidis, Yann C. Dhurandhar, Emily J. Veturi, Yogasudha C. Paulino, Paérez-rodríguez
Editor	Hsiao, Chuhsing Kate
Abstract	Lifestyle and genetic factors play a large role in the development of Type 2 Diabetes (T2D). Despite the important role of genetic factors, genetic information is not incorporated into the clinical assessment of T2D risk. We assessed and compared Whole Genome Regression methods to predict the T2D status of 5,245 subjects from the Framingham Heart Study. For evaluating each method we constructed the following set of regression models: A clinical baseline model (CBM) which included non-genetic covariates only. CBM was extended by adding the first two marker-derived principal components and 65 SNPs identified by a recent GWAS consortium for T2D (M-65SNPs). Subsequently, it was further extended by adding 249,798 genome-wide SNPs from a high-density array. The Bayesian models used to incorporate genome-wide marker information as predictors were: Bayes A, Bayes Cπ, Bayesian LASSO (BL), and the Genomic Best Linear Unbiased Prediction (G-BLUP). Results included estimates of the genetic variance and heritability, genetic scores for T2D, and predictive ability evaluated in a 10-fold cross-validation. The predictive AUC estimates for CBM and M-65SNPs were: 0.668 and 0.684, respectively. We found evidence of contribution of genetic effects in T2D, as reflected in the genomic heritability estimates (0.492±0.066). The highest predictive AUC among the genome-wide marker Bayesian models was 0.681 for the Bayesian LASSO. Overall, the improvement in predictive ability was moderate and did not differ greatly among models that included genetic information. Approximately 58% of the total number of genetic variants was found to contribute to the overall genetic variation, indicating a complex genetic architecture for T2D. Our results suggest that the Bayes Cπ and the G-BLUP models with a large set of genome-wide markers could be used for predicting risk to T2D, as an alternative to using high-density arrays when selected markers from large consortiums for a given complex trait or disease are unavailable.
Related Links	http://dx.doi.org/10.1371/journal.pone.0123818
Starting Page	123818
File Format	PDF
ISSN	19326203
e-ISSN	19326203
Journal	PLoS ONE
Issue Number	4
Volume Number	10
Language	English
Publisher	Public Library of Science
Publisher Date	2015-04-17
Access Restriction	Open
Rights Holder	Public Library of Science
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Genetic analysis of type 1 diabetes using whole genome approaches.

Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus

Genetic analysis of type 1 diabetes using whole genome approaches.

Quantitative assessment of single-cell whole genome amplification methods for detecting copy number variation using hippocampal neurons

Whole Transcriptome Analysis of the Effects of Type I Diabetes on Mouse Oocytes

Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles

A genome-wide search for Type II diabetes susceptibility genes in Chinese Hans

Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing

Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus

Assessment of Whole-Genome Regression for Type II Diabetes

Similar Documents

Genetic analysis of type 1 diabetes using whole genome approaches.

Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus

Genetic analysis of type 1 diabetes using whole genome approaches.

Quantitative assessment of single-cell whole genome amplification methods for detecting copy number variation using hippocampal neurons

Whole Transcriptome Analysis of the Effects of Type I Diabetes on Mouse Oocytes

Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles

A genome-wide search for Type II diabetes susceptibility genes in Chinese Hans

Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing

Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus

Assessment of Whole-Genome Regression for Type II Diabetes